The risks of cancer in older women with <i>BRCA</i> pathogenic variants: How far have we come?-Reference-Cited by-同舟云学术

The risks of cancer in older women with BRCA pathogenic variants: How far have we come?

Published:2022-12-26 Issue:6 Volume:129 Page:901-907
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Metcalfe Kelly A.¹²^ORCID,Gronwald Jacek³,Tung Nadine M.⁴,McCuaig Jeanna M.⁵,Eisen Andrea⁶,Elser Christine⁷,Foulkes William D.⁸,Neuhausen Susan L.⁹,Senter Leigha¹⁰,Moller Pal¹¹,Bordeleau Louise¹²,Fruscio Robert¹³,Velsher Lea¹⁴,Zakalik Dana¹⁵,Olopade Olufunmilayo I.¹⁶^ORCID,Eng Charis¹⁷,Pal Tuya¹⁸,Cullinane Carey A.¹⁹,Couch Fergus J.²⁰,Kotsopoulos Joanne¹²¹^ORCID,Sun Ping¹,Lubinski Jan³,Narod Steven A.¹²¹^ORCID

Affiliation:

1. Women's College Research Institute Women's College Hospital Toronto Ontario Canada

2. Lawrence S. Bloomberg Faculty of Nursing University of Toronto Toronto Ontario Canada

3. Departments of Genetics and Pathology Pomeranian Medical University Szczecin Poland

4. Beth Israel Deaconess Medical Center Boston Massachusetts USA

5. Familial Cancer Clinic Princess Margaret Hospital University Health Network Toronto Ontario Canada

6. Toronto‐Sunnybrook Regional Cancer Center Toronto Ontario Canada

7. Marvelle Koffler Breast Centre Mt. Sinai Hospital Toronto Ontario Canada

8. Program in Cancer Genetics Department of Oncology and Human Genetics McGill University Montréal Quebec Canada

9. Department of Population Sciences Beckman Research Institute of City of Hope Duarte California USA

10. Division of Human Genetics the Ohio State University Medical Center Comprehensive Cancer Center Columbus Ohio USA

11. Inherited Cancer Research Group Department for Medical Genetics Department of Tumor Biology The Norwegian Radium Hospital Oslo University Hospital Oslo Norway

12. Department of Oncology McMaster University Hamilton Ontario Canada

13. Department of Medicine and Surgery University of Milan Bicocca Monza Italy

14. North York General Hospital Toronto Ontario Canada

15. Cancer Genetics Program Beaumont Hospitals Royal Oak Michigan USA

16. Department of Medicine and Human Genetics University of Chicago Chicago Illinois USA

17. Genomic Medicine Institute Cleveland Clinic Cleveland Ohio USA

18. Department of Medicine Division of Genetic Medicine Vanderbilt University Medical Center and the Vanderbilt‐Ingram Cancer Center Nashville Tennessee USA

19. MemorialCare Long Beach Medical Center Long Beach California USA

20. Division of Experimental Pathology and Laboratory Medicine Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA

21. Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34615

Reference19 articles.

1. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

2. Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation

3. Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers

4. Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics;Cell Biology and Toxicology;2024-06-26

2. Genetic testing for hereditary breast cancer in Poland: 1998–2022;Hereditary Cancer in Clinical Practice;2023-06-13